Do You Have Questions?

REACH OUT TO US TODAY

 

Join us Monday, January 25, 2021 at 1:00p.m. CST for a virtual presentation on 

“Co-Occurring Disorders: Psychiatry and Substance Use

Presentation given by Dr. Abid K. Nazeer, M.D., Chief Medical Officer of Symetria Recovery 

Dr. Nazeer Final for Website

1.5 Hour CEU Credits Provided by NAADAC

Dr. Nazeer will present on the commonality between Mental Illness and Substance Use Disorder. He will describe addiction as a psychiatric condition and give you a look at the brain and associated symptoms. Dr. Abid Nazeer is board certified in Psychiatry and Addiction Medicine, as well as certified in BRIDGE medical device procedures for opiate withdrawal. He has expertise in pharmacogenetic testing and its clinical application, plus is a member of the American Society of Addiction Medicine (ASAM).

Dr. Nazeer oversees psychiatric and addiction medicine care at Symetria Recovery, responsible for guiding The Symetria Method protocol at the company’s network of treatment centers. He oversees medication management for patients with a co-existing psychiatric illness or those who are on medications for psychiatric diagnosis; educates staff and patients on the potential impact of unresolved psychiatric symptoms (such as anxiety or depression) can have on the recovery process; and oversees the development of treatment plans for patients with dual diagnosis.

Symetria Recovery is the pioneer and leader in complete, personalized, evidence-based recovery care through outpatient opioid, heroin, and alcohol (all substance use disorders) treatment committed to providing state-of-the-art, whole-person care, not just related to the substance misuse. Its unique approach to dependency is known as The Symetria Method. This method combines medication-assisted treatment (MAT), psychiatry, and support from a single treatment team of behavioral health, medical and psychiatric professionals to reduce the risk of relapse and give patients sustainable results. Symetria Recovery’s highly successful outcomes have been validated by an independent, retrospective analysis of more than 1.5 billion commercial claims from 3+ million Opioid Use Disorder patients for five years. The analysis demonstrates superior results on all metrics when compared with treatment as usual. 

Drug use and public health statistics indicate that in the United States, approximately 90% of treatment recipients later relapse, or return to using opioids or heroin. In response to this staggering statistic, we developed a more effective continuum of care that covers the stages of recovery from detoxification, medical management, continued care and relapse prevention. By treating the whole patient, and not just the addictive behavior, we provide superior lasting recovery.

We are dedicated to fighting the national opioid addiction epidemic by improving treatment outcomes through the implementation of best practices in the coordination of patient care.  Yes, more than 88% of patients quit opioids, for good.